Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microtubule binding	GAPDH CKAP5 GOLGA6B GOLGA6A EML5 CAMSAP2 TRIM46 EML4 GTSE1 NUMA1 GOLGA6C GOLGA6D LRPPRC MACF1	1.84e-05	308	235	14	GO:0008017
GeneOntologyMolecularFunction	tubulin binding	GAPDH CKAP5 BBS4 GOLGA6B GOLGA6A EML5 CAMSAP2 TRIM46 DIP2B EML4 GTSE1 NUMA1 GOLGA6C GOLGA6D LRPPRC MACF1	5.09e-05	428	235	16	GO:0015631
GeneOntologyMolecularFunction	importin-alpha family protein binding	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.56e-05	21	235	4	GO:0061676
GeneOntologyMolecularFunction	cytoskeletal protein binding	EPS8 GAPDH CKAP5 IMPACT BBS4 GOLGA6B GOLGA6A DLC1 EML5 CAMSAP2 USH2A UTRN TRIM46 DIP2B RARA EML4 ARPC1A GTSE1 NUMA1 GOLGA6C GOLGA6D FHOD3 ARPC1B LRPPRC LMO7 MACF1 SSH2	2.44e-04	1099	235	27	GO:0008092
GeneOntologyBiologicalProcess	asymmetric cell division	ETV5 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.60e-05	34	231	5	GO:0008356
GeneOntologyBiologicalProcess	Golgi disassembly	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.15e-05	18	231	4	GO:0090166
GeneOntologyBiologicalProcess	positive regulation of glycoprotein biosynthetic process	GOLGA6B GOLGA6A TCF7L2 GOLGA6C GOLGA6D	4.79e-05	36	231	5	GO:0010560
GeneOntologyBiologicalProcess	positive regulation of protein glycosylation	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.21e-05	19	231	4	GO:0060050
GeneOntologyBiologicalProcess	negative regulation of cytoskeleton organization	EPS8 FRMD7 BBS4 DLC1 CAMSAP2 SHANK1 EML4 CARMIL1 FHOD3 SSH2	6.98e-05	194	231	10	GO:0051494
GeneOntologyBiologicalProcess	negative regulation of supramolecular fiber organization	EPS8 FRMD7 BBS4 DLC1 CAMSAP2 SHANK1 EML4 CARMIL1 FHOD3 SSH2	7.93e-05	197	231	10	GO:1902904
GeneOntologyBiologicalProcess	positive regulation of glycoprotein metabolic process	GOLGA6B GOLGA6A TCF7L2 GOLGA6C GOLGA6D	8.06e-05	40	231	5	GO:1903020
GeneOntologyBiologicalProcess	regulation of cellular component size	EPS8 BBS4 PTPRS KDM6A TRIM46 DIP2B OGT CARMIL1 PCLO SMURF1 ALS2 FHOD3 MACF1 SSH2 SLC12A7	9.84e-05	426	231	15	GO:0032535
GeneOntologyBiologicalProcess	Golgi ribbon formation	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.15e-04	23	231	4	GO:0090161
GeneOntologyBiologicalProcess	regulation of protein glycosylation	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.37e-04	24	231	4	GO:0060049
MousePheno	increased alveolar macrophage number	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.30e-05	14	178	4	MP:0014228
MousePheno	abnormal alveolar macrophage number	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.11e-05	15	178	4	MP:0014227
Domain	ARM-type_fold	CKAP5 PSMD5 PSME4 PIK3C2G KPNA4 IPO5 HEATR4 MROH2A RTTN FHOD3 APOB XPO1 SDAD1 PPP2R5D LTN1	2.24e-05	339	231	15	IPR016024
Domain	WD_REPEATS_1	DCAF8 FBXW12 EDC4 EML5 MIOS EML4 ARPC1A GNB1L APAF1 ARPC1B TBL3 WDCP CFAP44	4.51e-05	278	231	13	PS00678
Domain	WD_REPEATS_2	DCAF8 FBXW12 EDC4 EML5 MIOS EML4 ARPC1A GNB1L APAF1 ARPC1B TBL3 WDCP CFAP44	4.68e-05	279	231	13	PS50082
Domain	WD_REPEATS_REGION	DCAF8 FBXW12 EDC4 EML5 MIOS EML4 ARPC1A GNB1L APAF1 ARPC1B TBL3 WDCP CFAP44	4.68e-05	279	231	13	PS50294
Domain	GOLGA2L5	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.09e-05	18	231	4	PF15070
Domain	Golgin_A	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.09e-05	18	231	4	IPR024858
Domain	-	DCAF8 FBXW12 EDC4 EML5 SEMA5B MIOS EML4 ARPC1A GNB1L APAF1 ARPC1B TBL3 WDCP CFAP44	7.30e-05	333	231	14	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DCAF8 FBXW12 EDC4 EML5 SEMA5B MIOS EML4 ARPC1A GNB1L APAF1 ARPC1B TBL3 WDCP CFAP44	7.78e-05	335	231	14	IPR015943
Domain	ARPC1	ARPC1A ARPC1B	1.52e-04	2	231	2	IPR017383
Domain	WD40_repeat	DCAF8 FBXW12 EDC4 EML5 MIOS EML4 ARPC1A GNB1L APAF1 ARPC1B TBL3 CFAP44	1.53e-04	272	231	12	IPR001680
Domain	HEAT_REPEAT	CKAP5 PSME4 IPO5 HEATR4 MROH2A XPO1	2.27e-04	70	231	6	PS50077
Domain	TPR_8	BBS4 ZC3H7B KDM6A OGT TMTC4	4.90e-04	53	231	5	PF13181
Domain	WD40	DCAF8 EDC4 EML5 MIOS EML4 ARPC1A GNB1L APAF1 ARPC1B TBL3 CFAP44	5.29e-04	268	231	11	SM00320
Domain	ARM-like	CKAP5 PSMD5 PSME4 KPNA4 IPO5 HEATR4 MROH2A RTTN FHOD3 XPO1 LTN1	5.63e-04	270	231	11	IPR011989
Domain	LRR_6	NLRP13 AMN1 CARMIL1 NLRP2 LRRC14	5.83e-04	55	231	5	PF13516
Domain	Dynein_heavy_chain_D4_dom	DNAH6 DNAH8 DNAH12	6.15e-04	14	231	3	IPR024317
Domain	Dynein_heavy_dom-2	DNAH6 DNAH8 DNAH12	6.15e-04	14	231	3	IPR013602
Domain	DHC_N2	DNAH6 DNAH8 DNAH12	6.15e-04	14	231	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH6 DNAH8 DNAH12	6.15e-04	14	231	3	IPR011704
Domain	AAA_8	DNAH6 DNAH8 DNAH12	6.15e-04	14	231	3	PF12780
Domain	AAA_5	DNAH6 DNAH8 DNAH12	6.15e-04	14	231	3	PF07728
Domain	SAM/pointed	MAP3K20 DLC1 EHF MAP3K15 SHANK1 ARAP3 TNKS2	6.33e-04	117	231	7	IPR013761
Domain	DHC_fam	DNAH6 DNAH8 DNAH12	7.61e-04	15	231	3	IPR026983
Domain	Dynein_heavy	DNAH6 DNAH8 DNAH12	7.61e-04	15	231	3	PF03028
Domain	Dynein_heavy_dom	DNAH6 DNAH8 DNAH12	7.61e-04	15	231	3	IPR004273
Domain	INF_lambda	IFNL2 IFNL3	8.99e-04	4	231	2	IPR029177
Domain	IL28A	IFNL2 IFNL3	8.99e-04	4	231	2	PF15177
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CKAP5 GOLGA6B GOLGA6A EDC4 ERBIN PTPRD PTPRS MIOS CAMSAP2 SHANK1 TRIM46 DIP2B OGT NUMA1 GOLGA6C GOLGA6D ARHGEF12 YWHAG LRPPRC PPP2R5D IGF2R UBA6 TJAP1 MACF1 SSH2 LRRC15	2.69e-09	963	236	26	28671696
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	EPS8 WWOX ITGA7 ERBIN CDKAL1 SLC39A6 UTRN MAPKAP1 DSC2 CARMIL1 APBB2 CACHD1 LRPPRC IGF2R GUSB MACF1 SLC12A7	5.67e-09	421	236	17	36976175
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	EPS8 IL16 GAPDH CKAP5 EDC4 ERBIN PTPRS SV2A MIOS FHL1 CAMSAP2 DNAH6 UTRN SHANK1 TRIM46 IPO5 OGT CARMIL1 PCLO ARPC1A SMURF1 ARHGEF12 XPO1 YWHAG ARPC1B LRPPRC LMO7 TRAPPC10 MACF1 SSH2 ABHD12	1.32e-08	1431	236	31	37142655
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	WWOX GAPDH CKAP5 MCM4 ERBIN CDKAL1 IPO5 RIOK1 DSC2 CARMIL1 GNB1L NUMA1 ARHGEF12 CACHD1 XPO1 YWHAG LRPPRC PPP2R5D IGF2R UBA6 MACF1	2.02e-08	708	236	21	39231216
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	GOLGA6B GOLGA6A EDC4 DNMBP UTRN CARMIL1 GTSE1 GOLGA6C GOLGA6D APBB2 IGF2R LTN1	6.70e-08	230	236	12	35449600
Pubmed	Pilt is a coiled-coil domain-containing protein that localizes at the trans-Golgi complex and regulates its structure.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D TJAP1	1.48e-07	19	236	5	22841714
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CKAP5 ERBIN KIRREL3 SV2A PLCL2 CAMSAP2 UBR2 SMURF1 ARHGEF12 GRB10 ALS2 FHIP2A LRIG3 MACF1 DISP2	1.49e-07	407	236	15	12693553
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	RAD18 DCAF8 MAP3K20 EDC4 ERBIN MITF MLLT3 CAMSAP2 MAPKAP1 PRKD2 RIOK1 L3MBTL2 ARPC1A GTSE1 GRB10 XPO1 FHIP2A YWHAG ARPC1B ARAP3 WDCP TJAP1 SSH2 DBR1	2.03e-07	1038	236	24	26673895
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	GAPDH CKAP5 PTPRD PTPRF SLC39A6 FHL1 PKN3 KPNA4 DSC2 CHAF1A GTSE1 TBL3 LGALS1	2.14e-07	307	236	13	37499664
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF597 ZNF384 RAD18 GAPDH CKAP5 PTPRF SV2A SLC39A6 DNAJC1 RMND1 ALG1 SHANK1 IPO5 TCF7L2 DGKE XPO1 ZNF317 INTS8 TBL3 SDAD1 LGALS1 RLF SLC7A1 PPP2R5D IGF2R TBC1D23	2.25e-07	1203	236	26	29180619
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCAF8 CKAP5 PSMD5 PTPRD NFE2L2 MLLT3 FHL1 UTRN KDM6A SHANK1 KPNA4 IPO5 NRBP1 PRKD2 OGT APBB2 CACHD1 INTS8 YWHAG SNRNP48 LMO7 ASB3 MACF1 ANKRD24 TBC1D23 TNKS2 ABHD12	2.26e-07	1285	236	27	35914814
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	A2M DCAF8 CKAP5 MCM4 CDKAL1 PTPRD PTPRF PTPRS RMND1 UTRN ALG1 IPO5 NRBP1 PRKD2 DIP2B OGT XPO1 RFC3 YWHAG LRPPRC ARAP3 LTN1 ABHD12	2.56e-07	974	236	23	28675297
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRF PTPRS	3.09e-07	3	236	3	20139422
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRF PTPRS	3.09e-07	3	236	3	33656439
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRF PTPRS	3.09e-07	3	236	3	9784606
Pubmed	LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.	PTPRD PTPRF PTPRS	3.09e-07	3	236	3	31985401
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	A2M SEMA5B ZC3H7B ANPEP L3MBTL2 MROH2A PCLO RTTN APAF1 FHOD3 APOB CMSS1 TBL3 SDAD1 DNAH12 MACF1	3.43e-07	496	236	16	31343991
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DCAF8 WWOX CACNA2D2 ERBIN PCNX2 PTPRS EHF ZSWIM4 UTRN KDM6A UBR2 DIP2B TCF7L2 OGT CARMIL1 SMURF1 APBB2 GRB10 H6PD INTS8 RLF SLC7A1 LRPPRC PPP2R3A GPR137C UBA6 TJAP1 MACF1 ANKRD24	3.76e-07	1489	236	29	28611215
Pubmed	Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D IGF2R	4.20e-07	23	236	5	18001291
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAP3K20 CKAP5 EDC4 ERBIN DLC1 DNMBP CAMSAP2 UTRN MAPKAP1 DIP2B DSC2 GRK7 CARMIL1 GTSE1 GRB10 ALS2 YWHAG LRPPRC LMO7 MACF1 SSH2	5.20e-07	861	236	21	36931259
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	A2M THNSL1 PSME4 ZC3H7B TASOR DDX11L8 ALG1 MAPKAP1 DIP2B RIOK1 OGT EML4 FHIP2A ARAP3 WDCP ASB3 DBR1 SLC12A7	5.82e-07	650	236	18	38777146
Pubmed	Brain development is impaired in c-fos -/- mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D FOSL1	6.56e-07	25	236	5	26143639
Pubmed	Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D IGF2R	6.56e-07	25	236	5	15078902
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	SEMA5B DNAH6 DNAH8 RIOK1 CARMIL1 RTTN APBB2 ARHGEF12 SSH2 CFAP44	6.77e-07	187	236	10	26460568
Pubmed	Disruption of Trip11 in cranial neural crest cells is associated with increased ER and Golgi stress contributing to skull defects in mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D SLC7A1	9.85e-07	27	236	5	35147267
Pubmed	The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1.	PTPRD PTPRF PTPRS	1.23e-06	4	236	3	8524829
Pubmed	Genetic modifiers of cystic fibrosis-related diabetes.	CDKAL1 TCF7L2 SLC26A9	1.23e-06	4	236	3	23670970
Pubmed	Globozoospermia and lack of acrosome formation in GM130-deficient mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.41e-06	13	236	4	28055014
Pubmed	GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.41e-06	13	236	4	33740186
Pubmed	Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.41e-06	13	236	4	28028212
Pubmed	GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.41e-06	13	236	4	29128360
Pubmed	Loss of GM130 does not impair oocyte meiosis and embryo development in mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.41e-06	13	236	4	32873390
Pubmed	GM130, a cis-Golgi protein, regulates meiotic spindle assembly and asymmetric division in mouse oocyte.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.41e-06	13	236	4	21552007
Pubmed	Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.	A2M IL16 WWOX GAPDH MCM4 CHAF1A CARMIL1 GTSE1 ARHGEF12 H6PD NLRP2 FUT2	1.78e-06	313	236	12	20800603
Pubmed	Golgb1 regulates protein glycosylation and is crucial for mammalian palate development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.96e-06	14	236	4	27226319
Pubmed	Cdk1 protects against oxygen-glucose deprivation and reperfusion-induced Golgi fragmentation and apoptosis through mediating GM130 phosphorylation.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.96e-06	14	236	4	37831422
Pubmed	GM130 and p115 play a key role in the organisation of the early secretory pathway during skeletal muscle differentiation.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.96e-06	14	236	4	30630895
Pubmed	Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.96e-06	14	236	4	33543287
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	CKAP5 CAMSAP2 GTSE1 YWHAG PPP2R5D MACF1	2.49e-06	57	236	6	29089450
Pubmed	Golgi disruption and early embryonic lethality in mice lacking USO1.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	23185636
Pubmed	Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	17189423
Pubmed	GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	26165940
Pubmed	The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	17046993
Pubmed	WDR38, a novel equatorial segment protein, interacts with the GTPase protein RAB19 and Golgi protein GM130 to play roles in acrosome biogenesis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	37635409
Pubmed	Golga5 is dispensable for mouse embryonic development and postnatal survival.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	28509431
Pubmed	Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	17204322
Pubmed	Demonstration of the expression and the enzymatic activity of N-acetylglucosaminyltransferase IX in the mouse brain.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	16413118
Pubmed	RhoA-mediated FMNL1 regulates GM130 for actin assembly and phosphorylates MAPK for spindle formation in mouse oocyte meiosis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.66e-06	15	236	4	26083584
Pubmed	Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.	PTPRD PTPRF PTPRS	3.05e-06	5	236	3	10777529
Pubmed	Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.	PTPRD PTPRF PTPRS	3.05e-06	5	236	3	22357843
Pubmed	The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development.	GOLGA6B GOLGA6A PTPRF GOLGA6C GOLGA6D MACF1	3.06e-06	59	236	6	26371508
Pubmed	Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization.	ETV5 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.27e-06	34	236	5	23533177
Pubmed	LIM kinase 2 is widely expressed in all tissues.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.53e-06	16	236	4	16399995
Pubmed	Molecular motor KIF1C is not essential for mouse survival and motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.53e-06	16	236	4	11784862
Pubmed	Molecular characterization of mitocalcin, a novel mitochondrial Ca2+-binding protein with EF-hand and coiled-coil domains.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.53e-06	16	236	4	16336229
Pubmed	SLC24A5 encodes a trans-Golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.53e-06	16	236	4	18166528
Pubmed	p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.53e-06	16	236	4	21640725
Pubmed	Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.	RAD18 RNF150 TRIM46 UBR2 SMURF1 LTN1 UBA6	4.03e-06	95	236	7	29643511
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EPS8 APTX MAP3K20 CKAP5 EDC4 ERBIN METTL18 MIOS DNAJC1 ZC3H7B DNMBP CAMSAP2 TASOR UTRN KPNA4 MAPKAP1 OGT CHAF1A ARHGEF12 CMSS1 INTS8 YWHAG TBL3 SDAD1 MED15 LTN1 MACF1	4.11e-06	1497	236	27	31527615
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	WWOX CDKAL1 SV2A ALG1 APBB2 PPP2R5D IGF2R GUSB TRAPPC10 TJAP1 TBC1D23	4.53e-06	285	236	11	34369648
Pubmed	The Protein Tyrosine Phosphatase MEG2 Regulates the Transport and Signal Transduction of Tropomyosin Receptor Kinase A.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.59e-06	17	236	4	27655914
Pubmed	Vesicle budding from endoplasmic reticulum is involved in calsequestrin routing to sarcoplasmic reticulum of skeletal muscles.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.59e-06	17	236	4	14728599
Pubmed	Dynamics and function of CXCR4 in formation of the granule cell layer during hippocampal development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.59e-06	17	236	4	28717168
Pubmed	Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.59e-06	17	236	4	14718562
Pubmed	A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.59e-06	17	236	4	20004763
Pubmed	mTORC1 signaling facilitates differential stem cell differentiation to shape the developing murine lung and is associated with mitochondrial capacity.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D LRPPRC	5.03e-06	37	236	5	36433959
Pubmed	Morphogenesis of the mouse neural plate depends on distinct roles of cofilin 1 in apical and basal epithelial domains.	ETV5 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.03e-06	37	236	5	25742799
Pubmed	A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D TCTN2	5.03e-06	37	236	5	21725307
Pubmed	p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.87e-06	18	236	4	15800058
Pubmed	Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.87e-06	18	236	4	20230794
Pubmed	Flightless, secreted through a late endosome/lysosome pathway, binds LPS and dampens cytokine secretion.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.87e-06	18	236	4	22718342
Pubmed	Expression, localization, and biochemical characterization of nicotinamide mononucleotide adenylyltransferase 2.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.87e-06	18	236	4	20943658
Pubmed	Yip1B isoform is localized at ER-Golgi intermediate and cis-Golgi compartments and is not required for maintenance of the Golgi structure in skeletal muscle.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.87e-06	18	236	4	25208654
Pubmed	Notch inhibition by the ligand DELTA-LIKE 3 defines the mechanism of abnormal vertebral segmentation in spondylocostal dysostosis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.87e-06	18	236	4	21147753
Pubmed	N-cadherin sustains motility and polarity of future cortical interneurons during tangential migration.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.87e-06	18	236	4	24227724
Pubmed	Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.87e-06	18	236	4	24367100
Pubmed	Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases.	PTPRD PTPRF PTPRS	6.08e-06	6	236	3	19273906
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ZNF384 GAPDH MAP3K20 CKAP5 MCM4 PSMD5 ERBIN PSME4 GMPPB UTRN L3MBTL2 EML4 NUMA1 XPO1 CMSS1 RFC3 YWHAG ARPC1B TBL3 LGALS1 RLF LRPPRC ARAP3 LTN1 MACF1	6.33e-06	1353	236	25	29467282
Pubmed	Cell influx and contractile actomyosin force drive mammary bud growth and invagination.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	34042944
Pubmed	Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	15452145
Pubmed	Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	38048369
Pubmed	Presenilin 1 and presenilin 2 have differential effects on the stability and maturation of nicastrin in Mammalian brain.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	12646573
Pubmed	Spatial regulation of Raf kinase signaling by RKTG.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	17724343
Pubmed	Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	14622145
Pubmed	SDF2L1 interacts with the ER-associated degradation machinery and retards the degradation of mutant proinsulin in pancreatic β-cells.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	23444373
Pubmed	CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	35705037
Pubmed	Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	17664336
Pubmed	Stage-dependent function of Wnt5a during male external genitalia development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	34255394
Pubmed	Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	7.39e-06	19	236	4	17003038
Pubmed	Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.19e-06	20	236	4	29437892
Pubmed	Furin is the primary in vivo convertase of angiopoietin-like 3 and endothelial lipase in hepatocytes.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.19e-06	20	236	4	23918928
Pubmed	The COPI vesicle complex binds and moves with survival motor neuron within axons.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.19e-06	20	236	4	21300694
Pubmed	Development of the post-natal growth plate requires intraflagellar transport proteins.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.19e-06	20	236	4	17359961
Pubmed	The molecular complex of ciliary and golgin protein is crucial for skull development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.19e-06	20	236	4	34128978
Pubmed	TMED2/emp24 is required in both the chorion and the allantois for placental labyrinth layer development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.19e-06	20	236	4	30236446
Pubmed	Intraflagellar transport molecules in ciliary and nonciliary cells of the retina.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.19e-06	20	236	4	20368623
Pubmed	Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.19e-06	20	236	4	31949138
Pubmed	Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.	PTPRD PTPRF PTPRS	1.06e-05	7	236	3	12376545
Pubmed	Risk Alleles in/near ADCY5, ADRA2A, CDKAL1, CDKN2A/B, GRB10, and TCF7L2 Elevate Plasma Glucose Levels at Birth and in Early Childhood: Results from the FAMILY Study.	CDKAL1 TCF7L2 GRB10	1.06e-05	7	236	3	27049325
Pubmed	Modulation of apoptotic response by LAR family phosphatases-cIAP1 signaling during urinary tract morphogenesis.	PTPRD PTPRF PTPRS	1.06e-05	7	236	3	29073098
Interaction	CLRN3 interactions	GOLGA6B GOLGA6A ERICH6 GOLGA6C GOLGA6D	2.31e-07	13	232	5	int:CLRN3
Interaction	PARD6B interactions	PSMD5 IPO5 UBR2 OGT ANPEP NUMA1 YWHAG ARAP3 LTN1 PLPBP	7.60e-06	146	232	10	int:PARD6B
GeneFamily	WD repeat domain containing	DCAF8 FBXW12 EML5 EML4 ARPC1A GNB1L APAF1 ARPC1B TBL3 CFAP44	1.23e-04	262	161	10	362
GeneFamily	Dyneins, axonemal	DNAH6 DNAH8 DNAH12	4.30e-04	17	161	3	536
GeneFamily	Forkhead boxes	FOXB2 FOXE3 FOXD3 FOXB1	5.70e-04	43	161	4	508
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRF PTPRS	8.19e-04	21	161	3	813
GeneFamily	NLR family	NLRC4 NLRP13 NLRP2	1.38e-03	25	161	3	666
GeneFamily	WD repeat domain containing\|Caspase recruitment domain containing\|Apoptosome	NLRC4 APAF1 CASP5	2.36e-03	30	161	3	959
GeneFamily	PDZ domain containing	IL16 ERBIN SHANK1 PCLO ARHGEF12 LMO7	2.42e-03	152	161	6	1220
GeneFamily	Actin related protein 2/3 complex	ARPC1A ARPC1B	2.72e-03	9	161	2	39
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	KIRREL3 PTPRD PTPRF PTPRS ADAMTSL3 LRIG3	3.22e-03	161	161	6	593
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKQ DGKE	3.38e-03	10	161	2	1178
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	BBS4 ZC3H7B KDM6A OGT TMTC4	3.68e-03	115	161	5	769
Coexpression	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	TRAF5 EARS2 ETV5 OGT EML4 XPO1 ZCCHC3 ASB3 LRRC14 KLHL12 ABHD12	1.34e-05	242	236	11	M904
Coexpression	GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN	EPS8 PTPRF PTPRS PRKD2 RIOK1 OGT SDAD1 IFNAR2 SSH2 TNKS2	1.46e-05	200	236	10	M8656
Coexpression	GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN	KIRREL3 PIK3C2G FHL1 USH2A PCLO APOB ARAP3 ZSCAN22	1.72e-05	124	236	8	M470
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 PTPRD PIK3C2G SLC26A9 CACHD1 LMO7 SNX25	6.67e-09	192	235	11	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	ABCA3 PDE4C CACNA2D2 ETV5 DLC1 EHF SLC26A9 CACHD1 LMO7 LRP2BP	6.61e-08	188	235	10	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 PTPRD EHF CACHD1 SNX25 LRP2BP	7.66e-08	191	235	10	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPS8 ABCA3 CACNA2D2 ETV5 EHF PCLO SLC26A9 CACHD1 RFC3 SNX25	8.05e-08	192	235	10	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 EHF SLC26A9 CACHD1 SNX25 LRP2BP	8.05e-08	192	235	10	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 PTPRD SLC26A9 CACHD1 SNX25 LRP2BP	8.45e-08	193	235	10	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 PTPRD SLC26A9 CACHD1 SNX25 LRP2BP	8.45e-08	193	235	10	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_2\|368C / Donor, Lineage, Cell class and subclass (all cells)	EARS2 EDC4 ANPEP L3MBTL2 RLF TMTC4 GUSB LTN1 CFAP44	3.32e-07	171	235	9	26b34dc069cc15b75a0c13cb8c5d81e074788160
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 PTPRD CACHD1 SNX25 LRP2BP	5.11e-07	180	235	9	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ABCA3 PDE4C CACNA2D2 DLC1 SLC26A9 CACHD1 LMO7 SNX25 LRP2BP	5.87e-07	183	235	9	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M PTPRD PIK3C2G ADAMTS16 USH2A MROH2A PCLO APOB ASXL3	6.14e-07	184	235	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M PTPRD PIK3C2G ADAMTS16 USH2A MROH2A PCLO APOB ASXL3	6.14e-07	184	235	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M PTPRD PIK3C2G ADAMTS16 USH2A MROH2A PCLO APOB ASXL3	6.14e-07	184	235	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	ABCA3 PDE4C CACNA2D2 ETV5 DLC1 EML4 SLC26A9 SNX25 LRP2BP	7.03e-07	187	235	9	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 RNF150 PIK3C2G NFE2L2 MITF ADAMTS16 APBB2 FHOD3 CACHD1	7.35e-07	188	235	9	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 SLC26A9 CACHD1 SNX25 LRP2BP	7.68e-07	189	235	9	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PTPRD FCGRT PTPRS FHL1 TCF7L2 GRB10 LGALS1 IGF2R MACF1	7.68e-07	189	235	9	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	EPS8 ABCA3 CACNA2D2 EHF PCLO SLC26A9 CACHD1 LMO7 SNX25	8.39e-07	191	235	9	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	ABCA3 CACNA2D2 DLC1 PTPRF EHF MLLT3 CACHD1 LMO7 SNX25	8.76e-07	192	235	9	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 EHF SLC26A9 CACHD1 SNX25	9.15e-07	193	235	9	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 PTPRD CARMIL1 SLC26A9 SNX25	9.55e-07	194	235	9	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EPS8 ABCA3 CACNA2D2 ETV5 PTPRD EHF SLC26A9 CACHD1 SNX25	1.13e-06	198	235	9	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	WWOX CDKAL1 MLLT3 UTRN KDM6A UBR2 DIP2B APBB2 SSH2	1.18e-06	199	235	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	367C-Epithelial_cells-Epithelial-B_(AT2)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 CACNA2D2 PTPRF EHF SLC26A9 RNF17 LMO7 SNX25	3.19e-06	168	235	8	16b517e3159ad6e6d25fd48f7d5f46e77b2b318d
ToppCell	367C-Epithelial_cells-Epithelial-B_(AT2)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 CACNA2D2 PTPRF EHF SLC26A9 RNF17 LMO7 SNX25	3.19e-06	168	235	8	e20e1936573fdde78426d7a4eb45c458d5c4dbb4
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	A2M MCM4 PTPRD FHL1 EPGN RFC3 LGALS1 MACF1	3.48e-06	170	235	8	e20568c8f3f17d94de78229617eb2f7e4c5af2bc
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	A2M EPS8 TRAF5 PDE4C DLC1 UTRN CARMIL1 APBB2	3.64e-06	171	235	8	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	USP18 CDKAL1 PTPRD GMPR FASTKD3 PCLO SLC7A1 TNKS2	4.69e-06	177	235	8	946803293a7955116c80f403e99e4093e798ca3f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPS8 ABCA3 CACNA2D2 DLC1 EHF CACHD1 SNX25 LRP2BP	5.99e-06	183	235	8	6847c1252d6bb105524f812658112517fd351eab
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	A2M EPS8 PDE4C DLC1 SEMA5B UTRN APBB2 ADAMTSL3	5.99e-06	183	235	8	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2G NFE2L2 MITF ADAMTS16 MAP3K15 APBB2 FHOD3 CACHD1	5.99e-06	183	235	8	2e831a4d99c6f983793df71c0994124c943c6da9
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	EPS8 ABCA3 CACNA2D2 EHF SLC26A9 CACHD1 LMO7 SNX25	6.24e-06	184	235	8	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	A2M EPS8 PDE4C DLC1 SEMA5B UTRN APBB2 ADAMTSL3	6.49e-06	185	235	8	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPS8 ABCA3 ETV5 SLC24A3 PTPRD TENT5A SLC26A9 CACHD1	6.75e-06	186	235	8	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MAP3K20 PTPRD PTPRS FHL1 H6PD LGALS1 IGF2R MACF1	7.30e-06	188	235	8	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 RNF150 PIK3C2G MITF ADAMTS16 APBB2 FHOD3 CACHD1	7.30e-06	188	235	8	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	PND10-Epithelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 ETV5 PTPRF EHF SLC26A9 LMO7 SNX25 CFAP44	7.59e-06	189	235	8	89349e226a5512833a94b1bf68056a6985fe4afd
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	WWOX RNF150 EHF GMPR UTRN APBB2 LMO7 SNX25	7.89e-06	190	235	8	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBIN PSME4 NFE2L2 TASOR MAPKAP1 DSC2 EML4 APOB	8.20e-06	191	235	8	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CACNA2D2 IMPACT PCNX2 PLCL2 PNOC FHOD3 YWHAG DISP2	8.20e-06	191	235	8	5d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCell	Entopeduncular-Neuronal-Inhibitory\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CACNA2D2 IMPACT PCNX2 PLCL2 PNOC FHOD3 YWHAG DISP2	8.20e-06	191	235	8	73dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBIN PSME4 NFE2L2 TASOR MAPKAP1 DSC2 EML4 APOB	8.20e-06	191	235	8	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M ABCA3 CACNA2D2 ETV5 DLC1 PTPRS SLC26A9 SNX25	8.20e-06	191	235	8	f00d6824bd138b192a996e9f7de57b235bb24c18
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBIN PSME4 NFE2L2 TASOR MAPKAP1 DSC2 EML4 APOB	8.20e-06	191	235	8	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ABCA3 CACNA2D2 DLC1 PTPRF EHF CACHD1 LMO7 SNX25	8.52e-06	192	235	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA3 ETV5 PTPRF EHF ANPEP SLC26A9 LMO7 SNX25	8.52e-06	192	235	8	13e4b17d7a592604140777aca235f795df6b3f91
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA3 ETV5 PTPRF EHF ANPEP SLC26A9 LMO7 SNX25	8.52e-06	192	235	8	6244541688f85917018a057aa0b3e5972934dfbc
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	WWOX CDKAL1 PTPRD DIP2B GRB10 FHOD3 MACF1 SSH2	8.52e-06	192	235	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RAD18 CKAP5 PKN3 CHAF1A GTSE1 RTTN CMSS1 RFC3	8.85e-06	193	235	8	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	PIK3C2G EHF PLCL2 ADAMTS16 MLLT3 MAP3K15 ADAMTSL3 SLC7A1	8.85e-06	193	235	8	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	(7)_Epithelial_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	EPS8 ABCA3 CACNA2D2 ETV5 PTPRF EHF LMO7 SNX25	9.18e-06	194	235	8	413e8b9f1e15be363a7f4a8f727af3eeb9e9a928
ToppCell	normal_Lung-Epithelial_cells\|normal_Lung / Location, Cell class and cell subclass	EPS8 ABCA3 CACNA2D2 DLC1 PTPRF EHF LMO7 SNX25	9.53e-06	195	235	8	7c90d887afde5c4d63352b5171be9987e2dfca58
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPS8 ABCA3 CACNA2D2 DLC1 PTPRF LMO7 SNX25 LRP2BP	9.53e-06	195	235	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	356C-Epithelial_cells-Epithelial-A_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 PTPRF LMO7 SNX25	9.90e-06	196	235	8	93a5d9b8bcff7d07596ef1f4f2b74f043835fc69
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M EPS8 MAP3K20 ITGA7 DLC1 UTRN TENT5A APBB2	9.90e-06	196	235	8	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	Mild\|World / Disease group and Cell class	USP18 ERAP2 UTRN KDM6A PRKD2 DDX60 ARPC1B SLFN12L	9.90e-06	196	235	8	5e4ed4a5a437cfa002b92775992a791e27aa4c27
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	WWOX SLC24A3 CDKAL1 PTPRD MLLT3 SMURF1 APBB2 SNX25	9.90e-06	196	235	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	ASK440-Epithelial-Type_2\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 SLC26A9 LMO7 SNX25	9.90e-06	196	235	8	754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCell	356C-Epithelial_cells-Epithelial-A_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 PTPRF LMO7 SNX25	9.90e-06	196	235	8	4715f19f844e7244fc4bc446cba7c8088c600fc3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M EPS8 MAP3K20 SLC24A3 RNF150 DLC1 FHL1 APBB2	1.03e-05	197	235	8	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M EPS8 MAP3K20 SLC24A3 RNF150 DLC1 FHL1 APBB2	1.03e-05	197	235	8	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	ASK428-Epithelial-Type_2\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	EPS8 ABCA3 CACNA2D2 ETV5 DLC1 TENT5A CACHD1 SNX25	1.07e-05	198	235	8	ec0d1801363adb70c6a26655b79d12b438c7417d
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EPS8 ABCA3 CACNA2D2 ETV5 SLC26A9 CACHD1 SNX25 LRP2BP	1.07e-05	198	235	8	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	A2M UTRN UBR2 OGT EML4 RTTN SLFN12L MACF1	1.11e-05	199	235	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	distal-1-Epithelial\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ABCA3 CACNA2D2 ETV5 PTPRF EHF SLC26A9 LMO7 SNX25	1.11e-05	199	235	8	9086dbb60863c3da2cc5d0a310f28596a01c52ca
ToppCell	Caecum-(5)_Dendritic_cell-(51)_cDC1\|Caecum / shred on region, Cell_type, and subtype	CYP2E1 RMI1 EHF ANPEP SH2B3 GPER1 LRIG3 FOXB1	1.11e-05	199	235	8	2b97fda45241b2ce7be904cf081cabcf3eb5ba1d
ToppCell	ASK428-Epithelial\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	EPS8 ABCA3 CACNA2D2 DLC1 PTPRF EHF LMO7 SNX25	1.11e-05	199	235	8	ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7
ToppCell	human_hepatoblastoma-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	EPS8 PSME4 KPNA4 TENT5A SMURF1 DGKE YWHAG MED15	1.11e-05	199	235	8	e9c83555d2197b740797a9f33b64f8f7a7ba1ee2
ToppCell	Caecum-Dendritic_cell-cDC1\|Caecum / Region, Cell class and subclass	CYP2E1 RMI1 EHF ANPEP SH2B3 GPER1 LRIG3 FOXB1	1.11e-05	199	235	8	9ab38a0060a883de6fe3da8cdac42e124d7981d9
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABCA3 ETV5 PTPRF EHF GNG5 UTRN TENT5A LMO7	1.15e-05	200	235	8	c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	A2M IL16 DLC1 FCGRT MITF GPER1 ARPC1B TRAPPC10	1.15e-05	200	235	8	a6f0f5f644b7262878b0b9d4d90ee407c4124dd9
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	A2M IL16 DLC1 FCGRT MITF GPER1 ARPC1B TRAPPC10	1.15e-05	200	235	8	aafe594c88710f8c53d59667cdac5035e08f5511
ToppCell	ASK440-Epithelial\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	EPS8 ABCA3 CACNA2D2 DLC1 PTPRF EHF LMO7 SNX25	1.15e-05	200	235	8	cb617e2a0ca82b470b473b8d5906bc8879c85718
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2G NFE2L2 ADAMTS16 APBB2 FHOD3 CACHD1 FOXB1	2.12e-05	158	235	7	7960337d87afecf2692ab65e5991f052ceddfacc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 PIK3C2G NFE2L2 ADAMTS16 APBB2 FHOD3 CACHD1	2.30e-05	160	235	7	8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 PIK3C2G NFE2L2 ADAMTS16 APBB2 FHOD3 CACHD1	2.30e-05	160	235	7	2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74
ToppCell	facs-Aorta-Heart-24m-Endothelial-coronary_vascular_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSPAN12 PKN3 PRKD2 PNPLA2 SLC7A1 ARAP3 SLC12A7	2.69e-05	164	235	7	5ee3729fab794d7acb172d14ec5d91aa1a61cd61
ToppCell	LV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	A2M EPS8 TRAF5 PDE4C DLC1 UTRN APBB2	2.80e-05	165	235	7	f37fd95adc95d7753cf6e55ae819976513c7ec77
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRAF5 OR1J2 ADAMTS16 USH2A GOLGA6D MUC2 IFNL3	3.02e-05	167	235	7	b0b2601c41c053b1caa6701ba2f5723e6059fb0a
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPACT FCGRT KDM6A TCF7L2 SMURF1 SSH2 ABHD12	3.14e-05	168	235	7	e979a4fbeb9f21048b47d69e6da75c57650697f2
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|368C / Donor, Lineage, Cell class and subclass (all cells)	CDKAL1 PTPRD GMPR ZSWIM4 FASTKD3 PCLO LRRC14	3.26e-05	169	235	7	0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	EARS2 EDC4 ANKRD13C L3MBTL2 TMTC4 LTN1 CFAP44	3.26e-05	169	235	7	c6e5b179461996ced6c7621dc01cec00d401f4e8
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	EARS2 EDC4 L3MBTL2 RLF TMTC4 LTN1 CFAP44	3.26e-05	169	235	7	ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	EPS8 MLLT3 ARHGEF12 CACHD1 RFC3 LRIG3 LMO7	3.39e-05	170	235	7	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	Epithelial-Epithelial-C_(AT2)\|Epithelial / shred on cell class and cell subclass (v4)	ABCA3 ETV5 ANPEP TENT5A SLC26A9 H6PD SNX25	3.79e-05	173	235	7	f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	A2M PODNL1 PTPRD RMND1 IFNAR2 DNAH12 LMO7	3.93e-05	174	235	7	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MCM4 PTPRD FHL1 ZNF317 RFC3 RNF17 MACF1	4.22e-05	176	235	7	d30241fb8119834d6e7b59efec3f92fc7a3d1247
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RNF150 ADAMTS16 GMPR RTTN FHOD3 XPO1 ASXL3	4.54e-05	178	235	7	dfed0fbf7a73b8a9e00178ec58dc4592b271c344
ToppCell	Mid-temporal_gyrus_(MTG)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE4C RNF150 KIRREL3 DNAH6 CACHD1 ANKRD24 CFAP44	4.54e-05	178	235	7	ad187db4c40b9078d54dd915c143e0172b2f47b8
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	PCNX2 RMI1 TCF7L2 SMURF1 APBB2 RFC3 TJAP1	4.70e-05	179	235	7	9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2G NFE2L2 ADAMTS16 MAP3K15 APBB2 FHOD3 CACHD1	4.70e-05	179	235	7	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 PIK3C2G NFE2L2 ADAMTS16 APBB2 FHOD3 CACHD1	5.04e-05	181	235	7	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAP3K20 RMI1 TCF7L2 SMURF1 APBB2 RFC3 TJAP1	5.04e-05	181	235	7	2b9b460239d67fd480cee60820cdb306109d3567
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MAP3K20 RMI1 TCF7L2 SMURF1 APBB2 RFC3 TJAP1	5.04e-05	181	235	7	2a1aa4a0ec7bc367857beaff543135e4345c835b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2G NFE2L2 MITF ADAMTS16 MAP3K15 APBB2 CACHD1	5.22e-05	182	235	7	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	E18.5-samps\|World / Age Group, Lineage, Cell class and subclass	USP18 ABCA3 PTPRF ALDH6A1 APBB2 IGF2R LMO7	5.22e-05	182	235	7	9649f15858d1ede73e068afc59df3ac367b49687
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE4C MAP3K20 ITGA7 UTRN ANPEP GPER1 LGALS1	5.22e-05	182	235	7	ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial-AT2\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ABCA3 ETV5 PTPRF EHF ANPEP SLC26A9 SNX25	5.41e-05	183	235	7	0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26
ToppCell	PND07-28-samps-Epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ABCA3 ETV5 PTPRF LIAT1 EHF SLC26A9 SNX25	5.41e-05	183	235	7	a98f1d71d82ed6cca996f74352ab834fb6e95206
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	A2M CACNA2D2 ERBIN UTRN TCF7L2 IGF2R MACF1	5.41e-05	183	235	7	f593a89b0aa8fffdfa403769916facfd30358521
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	BBS4 CDKAL1 DLC1 PSME4 MITF FHL1 ALDH6A1 KDM6A PNPLA2 TCF7L2 PCLO IFNAR2 TNKS2	1.05e-07	194	232	13	4727_DN
Drug	Omeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT_HG-U133A	ITGA7 ZC3H7B FHL1 UTRN PNPLA2 TCF7L2 RARA EML4 NUMA1 UBA6 TJAP1 DBR1 TCTN2	1.05e-07	194	232	13	2467_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A	APTX MAP3K20 PSME4 OGT RARA DSC2 SH2B3 SMURF1 FOSL1 PPP2R5D LRRC14 ZNF654 TCTN2	1.12e-07	195	232	13	1505_DN
Drug	Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A	PODNL1 CYP2E1 CACNA2D2 CDKAL1 MIOS ZC3H7B UTRN RARA SMURF1 GRB10 SLC1A7 LY6D TNKS2	1.26e-07	197	232	13	3372_DN
Drug	0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A	PODNL1 ETV5 ZC3H7B ALDH6A1 NUMA1 SMURF1 DGKE CALHM2 SLC7A1 LRRC14 ZMYM6 TCTN2	4.94e-07	186	232	12	6900_UP
Drug	vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A	PODNL1 MLLT3 ZC3H7B ALDH6A1 KDM6A GNB1L SMURF1 FOSL1 PPP2R3A LRRC14 DBR1 TCTN2	9.61e-07	198	232	12	7551_DN
Drug	PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A	PODNL1 SLC24A3 DLC1 PSME4 ZC3H7B DSC2 NUMA1 H6PD RNF17 CALHM2 LY6D MUC2	1.07e-06	200	232	12	3773_UP
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	TSPAN12 IL16 MLLT3 GMPR ALDH6A1 TRIM46 TCF7L2 DSC2 APAF1 NUMA1 DGKE	3.47e-06	186	232	11	4460_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	ZNF862 ITGA7 PCNX2 SV2A MLLT3 CAMSAP2 ALDH6A1 NUMA1 APBB2 TJAP1 CFAP44	4.49e-06	191	232	11	2137_UP
Drug	PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A	ZNF862 ETV5 PCNX2 DLC1 GMPR RARA GNB1L APBB2 DGKE PPP2R3A PLPBP	5.21e-06	194	232	11	5923_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A	PODNL1 MCM4 MLLT3 RMND1 FHL1 DDX60 NUMA1 APBB2 DGKE RFC3 PLPBP	5.47e-06	195	232	11	3714_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	PODNL1 ETV5 PTPRS MITF FHL1 RARA NUMA1 APBB2 FOSL1 FUT2 LRRC15	5.74e-06	196	232	11	3409_UP
Drug	Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ETV5 CDKAL1 DLC1 PTPRS FHL1 RARA DGKE H6PD SLC1A7 LRRC14 TNKS2	5.74e-06	196	232	11	4739_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	DCAF8 BBS4 PCNX2 PSME4 PLCL2 ZC3H7B KDM6A PRKD2 OGT DSC2 GNB1L	6.03e-06	197	232	11	5815_DN
Drug	5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA	DCAF8 APTX CDKAL1 ZC3H7B FHL1 TASOR KDM6A GPER1 FOSL1 SLC7A1 PPP2R3A	6.03e-06	197	232	11	834_DN
Drug	Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	A2M PDE4C GMPR ZC3H7B UTRN TCF7L2 RARA DSC2 NUMA1 ARHGEF12 RNF17	6.64e-06	199	232	11	2765_UP
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CDKAL1 MITF GMPR ZC3H7B UTRN IPO5 TCF7L2 RARA GPER1 SMURF1 SLC1A7	6.96e-06	200	232	11	5395_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	ZNF862 DGKQ MITF ZC3H7B SHANK1 TCF7L2 NUMA1 CALHM2 MED15 CFAP44	2.22e-05	186	232	10	6987_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	ZNF862 GMPR ZC3H7B GPER1 PCLO APBB2 H6PD CALHM2 TJAP1 LRRC14	2.33e-05	187	232	10	5233_UP
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	CDKAL1 MLLT3 ALDH6A1 UTRN TCF7L2 DSC2 UBA6 TNKS2 ZMYM6 TCTN2	2.55e-05	189	232	10	3788_DN
Drug	Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A	PODNL1 WWOX ETV5 DGKQ PCNX2 DLC1 FHL1 PNPLA2 GRB10 FOSL1	2.55e-05	189	232	10	7206_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	ETV5 PSME4 EHF TCF7L2 DSC2 NUMA1 APBB2 IFNAR2 SLC7A1 PPP2R3A	2.79e-05	191	232	10	4279_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA	TRAF5 ABCA3 PTPRF FASTKD3 IPO5 MAPKAP1 OGT APBB2 IFNAR2 UBA6	2.92e-05	192	232	10	1068_DN
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	PDE4C WWOX CACNA2D2 PLCL2 MLLT3 ZC3H7B UTRN PNPLA2 RARA TCTN2	3.19e-05	194	232	10	4492_DN
Drug	Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A	PODNL1 CACNA2D2 ZNF862 CDKAL1 PSME4 RARA DSC2 APAF1 ARHGEF12 IL22	3.33e-05	195	232	10	3670_DN
Drug	Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; HL60; HT_HG-U133A	ZC3H7B CAMSAP2 NRBP1 TCF7L2 APAF1 NUMA1 SLC7A1 PPP2R5D IL22 TJAP1	3.33e-05	195	232	10	2470_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	PDE4C PTPRS ZC3H7B DNMBP CAMSAP2 PNOC TCF7L2 APAF1 NUMA1 TJAP1	3.33e-05	195	232	10	6163_DN
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	WWOX GAPDH MCM4 DLC1 PTPRF RMND1 ZC3H7B FHL1 NRBP1 CHAF1A	3.33e-05	195	232	10	6583_UP
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	THNSL1 IMPACT BBS4 PCNX2 PSME4 ZC3H7B PNPLA2 DSC2 APBB2 ARHGEF12	3.48e-05	196	232	10	6267_DN
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ZNF862 SLC24A3 MITF KDM6A KPNA4 TCF7L2 GNB1L LY6D TRAPPC10 LRRC14	3.48e-05	196	232	10	2811_DN
Drug	Cinchonine [118-10-5]; Up 200; 13.6uM; HL60; HT_HG-U133A	PCNX2 ZC3H7B FHL1 PNPLA2 PCLO APAF1 NUMA1 SMURF1 SLC1A7 CALHM2	3.48e-05	196	232	10	2133_UP
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A	DCAF8 MAP3K20 FHL1 UTRN DSC2 SH2B3 NUMA1 SMURF1 DGKE PPP2R3A	3.48e-05	196	232	10	6038_DN
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A	A2M PDE4C ZNF862 SLC24A3 PTPRD UTRN PNPLA2 GRB10 ADAMTSL3 MED15	3.48e-05	196	232	10	5533_UP
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	A2M IL16 WWOX FHL1 KDM6A DGKE PPP2R3A PPP2R5D IL22 TJAP1	3.64e-05	197	232	10	4708_UP
Drug	Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A	MAP3K20 ETV5 PSME4 PLCL2 ALDH6A1 RARA GPER1 DDX60 IFNAR2 TNKS2	3.64e-05	197	232	10	1799_DN
Drug	Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A	ZNF862 IMPACT SV2A DNAJC1 CAMSAP2 TCF7L2 NUMA1 APBB2 TRAPPC10 TJAP1	3.64e-05	197	232	10	2514_DN
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A	CDKAL1 KDM6A OGT GNB1L NUMA1 DGKE SLC7A1 PPP2R3A IL22 MACF1	3.64e-05	197	232	10	2768_DN
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A	DCAF8 TCF7L2 RARA DSC2 CHAF1A NUMA1 SMURF1 GRB10 LY6D PPP2R3A	3.64e-05	197	232	10	7037_DN
Drug	Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A	BBS4 PSME4 RMND1 FHL1 UTRN KDM6A APBB2 MED15 DBR1 CFAP44	3.64e-05	197	232	10	7293_DN
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	BBS4 UTRN PRKD2 EML4 APAF1 GRB10 TRAPPC10 TJAP1 LRRC14 TCTN2	3.79e-05	198	232	10	1332_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A	ABCA3 CYP2E1 ZNF862 PCNX2 ERAP2 EHF ALDH6A1 UTRN OGT SMURF1	3.79e-05	198	232	10	5799_DN
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A	A2M PODNL1 WWOX CDKAL1 PCNX2 GMPR FHL1 RARA SLC1A7 TCTN2	3.79e-05	198	232	10	5452_DN
Drug	Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	ZNF862 GMPR PNPLA2 TCF7L2 RARA DSC2 GPER1 NUMA1 SMURF1 TCTN2	3.79e-05	198	232	10	5414_DN
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; PC3; HT_HG-U133A	ABCA3 WWOX ZNF862 APTX PCNX2 ALDH6A1 DDX60 ARHGEF12 CALHM2 LMO7	3.79e-05	198	232	10	6738_DN
Drug	Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; MCF7; HT_HG-U133A	TSPAN12 ETV5 EHF MITF UTRN APBB2 ARHGEF12 ADAMTSL3 SLC7A1 TNKS2	3.79e-05	198	232	10	3509_UP
Drug	Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	ZNF862 MCM4 EHF MITF UTRN PNPLA2 OGT PCLO SMURF1 DBR1	3.79e-05	198	232	10	2062_DN
Drug	Diclofenac sodium [15307-79-6]; Up 200; 12.6uM; MCF7; HT_HG-U133A	PODNL1 ZNF862 GMPR APAF1 NUMA1 APBB2 H6PD SLC1A7 IL22 FUT2	3.79e-05	198	232	10	7215_UP
Drug	Oxybenzone [131-57-7]; Up 200; 17.6uM; MCF7; HT_HG-U133A	CYP2E1 SLC24A3 ITGA7 DLC1 PLCL2 DDX60 GRB10 RNF17 SLC7A1 ZMYM6	3.96e-05	199	232	10	6469_UP
Drug	Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A	ZNF862 DGKQ SV2A FHL1 ANPEP DDX60 APAF1 RNF17 LMO7 LRRC14	3.96e-05	199	232	10	3614_UP
Drug	wortmannin; Down 200; 0.01uM; HL60; HG-U133A	ETV5 PSMD5 PTPRD DNMBP PNOC RARA APBB2 ARHGEF12 RNF17 FOSL1	3.96e-05	199	232	10	389_DN
Drug	Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A	ZNF384 WWOX MCM4 DSC2 CHAF1A ARHGEF12 LY6D UBA6 TJAP1 PLPBP	3.96e-05	199	232	10	4649_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	THNSL1 TCF7L2 DSC2 ARHGEF12 GRB10 FOSL1 LY6D PPP2R3A WDCP LRRC14	3.96e-05	199	232	10	7000_DN
Drug	Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; PC3; HT_HG-U133A	PODNL1 ABCA3 CYP2E1 CACNA2D2 PCNX2 EHF ALDH6A1 DDX60 SLC1A7 LY6D	3.96e-05	199	232	10	7362_UP
Drug	Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	THNSL1 WWOX PCNX2 KDM6A SH2B3 GPER1 DGKE LY6D TRAPPC10 LRRC14	4.13e-05	200	232	10	2652_DN
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; HL60; HT_HG-U133A	BBS4 PTPRS PLCL2 ZC3H7B CAMSAP2 UTRN CARMIL1 APAF1 NUMA1 SMURF1	4.13e-05	200	232	10	2141_UP
Drug	3-hydroxy-3-methyloxindole	WWOX CYP2E1 GUSB	8.38e-05	9	232	3	CID000151066
Drug	glycidamide	TRAF5 WWOX CYP2E1 GAPDH MITF IGF2R HBE1	8.47e-05	102	232	7	CID000091550
Drug	ammonium;pyruvate	WWOX UCP1	1.03e-04	2	232	2	CID010129915
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ETV5 ZC3H7B FHL1 PNPLA2 TCF7L2 DSC2 SMURF1 APBB2 GRB10	1.09e-04	182	232	9	7422_UP
Drug	diethyl maleate	USP18 GAPDH MCM4 NFE2L2 DNMBP DDX60 TENT5A GTSE1 APAF1 H6PD LRIG3 LMO7	1.11e-04	318	232	12	ctd:C014476
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	THNSL1 SLC24A3 CDKAL1 MLLT3 UTRN TCF7L2 APBB2 PPP2R3A MACF1	1.14e-04	183	232	9	5613_DN
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ZNF862 ETV5 PCNX2 MITF ZC3H7B ARHGEF12 FOSL1 SLC7A1 TJAP1	1.29e-04	186	232	9	6793_UP
Drug	C768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA	WWOX PSME4 MLLT3 FASTKD3 KPNA4 OGT EML4 RFC3 DBR1	1.34e-04	187	232	9	973_DN
Drug	celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA	DCAF8 DLC1 IPO5 MAPKAP1 CHAF1A CALHM2 IFNAR2 PPP2R3A DBR1	1.34e-04	187	232	9	887_DN
Drug	Hycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A	PDE4C MCM4 MITF ZC3H7B TCF7L2 RARA DDX60 MACF1 TCTN2	1.34e-04	187	232	9	1614_DN
Drug	1,2-dicaprin	DGKQ PKN3 PRKD2 DGKE LGALS1	1.39e-04	49	232	5	CID000001321
Drug	NSC319051	GAPDH NLRC4 NFE2L2 ANPEP H6PD FOSL1	1.46e-04	78	232	6	CID000000842
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	PSME4 TASOR UBR2 TCF7L2 APAF1 MED15 PPP2R3A TRAPPC10 LRRC14	1.51e-04	190	232	9	2619_DN
Drug	Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A	MAP3K20 ETV5 PSME4 FHL1 PNOC APAF1 APBB2 ARHGEF12 TJAP1	1.51e-04	190	232	9	2465_DN
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A	MCM4 EDC4 CDKAL1 DNAJC1 DNMBP GPER1 ARHGEF12 GRB10 ZMYM6	1.51e-04	190	232	9	7070_UP
Drug	(S)-1,2-Diolein	CKAP5 DGKQ PKN3 PRKD2 DGKE	1.53e-04	50	232	5	CID000001324
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A	BBS4 FHL1 ALDH6A1 DSC2 SMURF1 DGKE PPP2R3A IGF2R ZMYM6	1.57e-04	191	232	9	1665_UP
Drug	Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	PODNL1 CYP2E1 CDKAL1 PCNX2 ZC3H7B RARA DSC2 ARHGEF12 DGKE	1.57e-04	191	232	9	2250_DN
Drug	3-hexanol	WWOX CYP2E1 GUSB	1.62e-04	11	232	3	CID000012178
Drug	Tempamine	A2M WWOX GAPDH	1.62e-04	11	232	3	CID000550942
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ZNF862 MAP3K20 ZC3H7B FHL1 PNPLA2 RARA APBB2 DGKE SLC1A7	1.63e-04	192	232	9	5401_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	PSME4 ZC3H7B KDM6A PNPLA2 DSC2 SLC7A1 TJAP1 TNKS2 TCTN2	1.63e-04	192	232	9	4743_DN
Drug	pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A	THNSL1 DCAF8 WWOX ETV5 APAF1 NUMA1 CALHM2 IFNAR2 LRRC14	1.63e-04	192	232	9	6898_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	EPS8 ITGA7 PCNX2 SV2A MLLT3 DNMBP CAMSAP2 APBB2 ARHGEF12	1.63e-04	192	232	9	1284_UP
Drug	Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A	THNSL1 CDKAL1 DLC1 UCP1 MIOS FOXE3 DDX60 APAF1 SLC1A7	1.70e-04	193	232	9	4503_UP
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A	ABCA3 PTPRF FCGRT UTRN DSC2 EML4 MED15 UBA6 MACF1	1.70e-04	193	232	9	6751_DN
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	ZNF862 ETV5 BBS4 CHAF1A SMURF1 APBB2 DGKE MED15 IL22	1.77e-04	194	232	9	3861_DN
Drug	Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A	PODNL1 PDE4C SLC24A3 CDKAL1 MIOS ZC3H7B ANPEP GPER1 APBB2	1.77e-04	194	232	9	2775_UP
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A	A2M DCAF8 FHL1 DNMBP PNPLA2 SH2B3 CHAF1A SMURF1 GRB10	1.77e-04	194	232	9	5454_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A	BBS4 MLLT3 DNAJC1 UTRN APAF1 APBB2 TRAPPC10 TJAP1 TCTN2	1.77e-04	194	232	9	1310_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	DCAF8 WWOX ZNF862 MCM4 GMPR PNPLA2 NUMA1 DGKE SLC7A1	1.77e-04	194	232	9	3840_DN
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A	CDKAL1 GMPR ZC3H7B UTRN RARA DSC2 FOSL1 TNKS2 TCTN2	1.83e-04	195	232	9	5424_DN
Drug	Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; HL60; HT_HG-U133A	ZNF862 TCF7L2 EML4 GTSE1 APAF1 TRAPPC10 TJAP1 ZMYM6 TCTN2	1.83e-04	195	232	9	2478_DN
Drug	Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ZNF862 MAP3K20 ETV5 SLC24A3 CDKAL1 GMPR DSC2 GRB10 MED15	1.83e-04	195	232	9	5631_DN
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A	CACNA2D2 PSME4 FHL1 PNPLA2 TCF7L2 FOSL1 MED15 SLC7A1 PPP2R3A	1.83e-04	195	232	9	3269_DN
Drug	Metolazone [17560-51-9]; Down 200; 11uM; PC3; HG-U133A	ERBIN NFE2L2 METTL18 FHL1 IPO5 TCF7L2 GRB10 UBA6 MACF1	1.83e-04	195	232	9	1932_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	THNSL1 MAP3K20 PSME4 ALDH6A1 IPO5 TCF7L2 DSC2 NUMA1 TNKS2	1.83e-04	195	232	9	4398_DN
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A	IL16 PDE4C ETV5 MCM4 NRBP1 RARA GTSE1 APAF1 MACF1	1.83e-04	195	232	9	1420_DN
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	PODNL1 DGKQ KDM6A DSC2 SMURF1 GRB10 SLC1A7 MUC2 ZMYM6	1.91e-04	196	232	9	7409_UP
Drug	Crotamiton [483-63-6]; Down 200; 19.6uM; PC3; HT_HG-U133A	ERAP2 EHF MITF GMPR ZC3H7B SMURF1 ARHGEF12 SLC1A7 LY6D	1.91e-04	196	232	9	4628_DN
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DCAF8 MAP3K20 ZC3H7B TCF7L2 EML4 NUMA1 PPP2R3A WDCP ZNF654	1.91e-04	196	232	9	7022_DN
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A	PDE4C BBS4 MCM4 KDM6A TCF7L2 OGT PPP2R5D LRRC14 TCTN2	1.91e-04	196	232	9	5975_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	CYP2E1 ZNF862 FHL1 TCF7L2 EML4 APBB2 TJAP1 ZMYM6 TCTN2	1.91e-04	196	232	9	2318_DN
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A	DCAF8 WWOX MAP3K20 SLC24A3 TCF7L2 RARA NUMA1 CALHM2 PPP2R3A	1.91e-04	196	232	9	7024_DN
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; HL60; HT_HG-U133A	ETV5 MLLT3 DNMBP UTRN TCF7L2 CHAF1A NUMA1 H6PD SLC7A1	1.91e-04	196	232	9	1289_UP
Disease	ghrelin measurement	WWOX MITF UTRN FOXE3 RFC3	3.36e-05	49	222	5	EFO_0600001
Disease	ACUTE PROMYELOCYTIC LEUKEMIA	RARA NUMA1	5.64e-05	2	222	2	612376
Disease	Acute promyelocytic leukemia	RARA NUMA1	5.64e-05	2	222	2	cv:C0023487
Disease	pro‐interleukin‐16 measurement	IL16 MLLT3 ADAMTSL3	6.63e-05	11	222	3	EFO_0010629
Disease	C-X-C motif chemokine 9 measurement	SH2B3 SDAD1	1.68e-04	3	222	2	EFO_0022032
Disease	epilepsy (implicated_via_orthology)	WWOX CACNA2D2 SLC24A3 ITGA7 SV2A SLC1A7 SLC12A7	2.45e-04	163	222	7	DOID:1826 (implicated_via_orthology)
Disease	hematocrit	WWOX FRMD7 CDKAL1 FCGRT PLCL2 MITF MLLT3 TASOR TRIM46 SHLD2 TCF7L2 SH2B3 CHAF1A APOB ASB3 SSH2 FUT2 HBE1 ABHD12	2.51e-04	1011	222	19	EFO_0004348
Disease	Colorectal Carcinoma	ABCA3 GAPDH DLC1 PTPRD PTPRS CAMSAP2 DNAH8 KDM6A SHANK1 TCF7L2 APOB ADAMTSL3 SLC1A7 ARAP3 LMO7	3.03e-04	702	222	15	C0009402
Disease	colorectal cancer (is_implicated_in)	CYP2E1 DLC1 KDM6A TCF7L2 SH2B3 XPO1	3.17e-04	121	222	6	DOID:9256 (is_implicated_in)
Disease	obsessive-compulsive disorder, autism spectrum disorder	FBXW12 DLC1 FOXB1	3.72e-04	19	222	3	EFO_0003756, EFO_0004242
Disease	late-onset Alzheimers disease	CKAP5 DLC1 PTPRS MLLT3 DNAH6 MRPL45 LRIG3 ASB3 FUT2	3.94e-04	292	222	9	EFO_1001870
Disease	antibody measurement	PTPRD NEK5 ASXL3 FUT2	5.07e-04	49	222	4	EFO_0004556
Disease	type 1 diabetes mellitus	DGKQ CAMSAP2 PRKD2 TCF7L2 SH2B3 GRB10 LMO7 FUT2	5.22e-04	242	222	8	MONDO_0005147
Disease	hepatocellular adenoma (biomarker_via_orthology)	A2M CYP2E1	5.55e-04	5	222	2	DOID:0050868 (biomarker_via_orthology)
Disease	JT interval	RNF150 MITF GMPR TASOR RIOK1 FHOD3 LRIG3 SLC12A7	6.13e-04	248	222	8	EFO_0007885
Disease	gout	CYP2E1 PTPRD MITF TRIM46 PRKD2 SHLD2 CARMIL1	7.40e-04	196	222	7	EFO_0004274
Disease	azoospermia (implicated_via_orthology)	PTPRD PTPRF PTPRS	1.08e-03	27	222	3	DOID:14227 (implicated_via_orthology)
Disease	non-high density lipoprotein cholesterol measurement	PDE4C DGKQ CDKAL1 DLC1 FCGRT MITF PKN3 DIP2B SH2B3 CARMIL1 APOB EPGN IGF2R FUT2	1.08e-03	713	222	14	EFO_0005689
Disease	peritonitis (biomarker_via_orthology)	A2M GUSB	1.15e-03	7	222	2	DOID:8283 (biomarker_via_orthology)
Disease	Irido-corneo-trabecular dysgenesis (disorder)	FOXE3 FOXD3	1.15e-03	7	222	2	C0344559
Disease	CC16 measurement	EHF TRIM46	1.15e-03	7	222	2	EFO_0005080
Disease	acute promyelocytic leukemia (is_implicated_in)	RARA NUMA1	1.15e-03	7	222	2	DOID:0060318 (is_implicated_in)
Disease	Calcium channel blocker use measurement	TRIM46 MAPKAP1 SH2B3 ARPC1A ARPC1B SLC7A1 LRPPRC	1.20e-03	213	222	7	EFO_0009930
Disease	smoking behaviour measurement	MAP3K20 SLC24A3 RMI1 PTPRF PLCL2 MAPKAP1 LRPPRC	1.52e-03	222	222	7	EFO_0005671
Disease	gestational diabetes (is_implicated_in)	CDKAL1 TCF7L2	1.53e-03	8	222	2	DOID:11714 (is_implicated_in)
Disease	insulin sensitivity measurement, insulin response measurement	CDKAL1 GRB10	1.53e-03	8	222	2	EFO_0004471, EFO_0008473
Disease	sclerosing cholangitis	PRKD2 TCF7L2 SH2B3 FUT2	1.56e-03	66	222	4	EFO_0004268
Disease	testosterone measurement	WWOX C3orf38 SLC24A3 NLRC4 RMI1 PTPRF FCGRT NFE2L2 SV2A DNMBP USH2A UTRN PKN3 DIP2B EML4 IFNAR2 ASB3 MACF1 TNKS2 ZNF654	1.63e-03	1275	222	20	EFO_0004908
Disease	intraocular pressure measurement	CKAP5 DLC1 PNPLA2 TCF7L2 ANPEP SH2B3 PCLO GNB1L ARHGEF12 PPP2R3A LMO7	1.75e-03	509	222	11	EFO_0004695
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	SEMA5B NRBP1 TCF7L2 APOB	1.84e-03	69	222	4	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	breast carcinoma	WWOX CDKAL1 PTPRD PLCL2 ADAMTS16 DNAJC1 ZC3H7B SHANK1 TRIM46 PRKD2 TCF7L2 L3MBTL2 TENT5A POLR2J ARHGEF12 CMSS1 SLC7A1	1.92e-03	1019	222	17	EFO_0000305
Disease	type 2 diabetes mellitus (is_implicated_in)	CDKAL1 PIK3C2G UCP1 TCF7L2 APOB IGF2R	1.92e-03	171	222	6	DOID:9352 (is_implicated_in)
Disease	excessive daytime sleepiness measurement	SLC24A3 TENT5A ASB3	1.94e-03	33	222	3	EFO_0007875
Disease	bringing up phlegm, sputum or mucus on most days, self-reported	FUT2 MUC2	1.96e-03	9	222	2	EFO_0009824
Disease	insulin response measurement	CDKAL1 GRB10	1.96e-03	9	222	2	EFO_0008473
Disease	X-17653 measurement	HEATR4 FUT2	1.96e-03	9	222	2	EFO_0800783
Disease	electroencephalogram measurement	PCNX2 PTPRD MITF MLLT3	2.38e-03	74	222	4	EFO_0004357
Disease	loneliness measurement	C3orf38 PTPRD UTRN TCF7L2 MACF1	2.51e-03	124	222	5	EFO_0007865
Disease	angina pectoris	FHL1 TENT5A CARMIL1 ARHGEF12 APOB	2.60e-03	125	222	5	EFO_0003913
Disease	urate measurement, bone density	WWOX ERBIN CDKAL1 KIRREL3 PTPRD ADAMTS16 USH2A DNAH8 UTRN TCF7L2 CARMIL1 ASB3	2.70e-03	619	222	12	EFO_0003923, EFO_0004531
Disease	X-11308 measurement	HEATR4 FUT2	2.96e-03	11	222	2	EFO_0800693
Disease	quality of life during menstruation measurement, acne	TENT5A FHOD3	2.96e-03	11	222	2	EFO_0003894, EFO_0009366
Disease	colon cancer (biomarker_via_orthology)	CYP2E1 APAF1 MUC2	3.14e-03	39	222	3	DOID:219 (biomarker_via_orthology)
Disease	Pathological accumulation of air in tissues	ABCA3 NFE2L2	3.54e-03	12	222	2	C0013990
Disease	Dental enamel hypoplasia	PTPRD SEMA5B	3.54e-03	12	222	2	EFO_1001304
Disease	Congenital muscular dystrophy	ITGA7 GMPPB	3.54e-03	12	222	2	cv:C0699743
Disease	peripheral arterial disease, traffic air pollution measurement	IL16 WWOX UTRN TCF7L2 GPR137C MACF1	3.60e-03	194	222	6	EFO_0004265, EFO_0007908
Disease	nose morphology measurement	WWOX C3orf38 DLC1 EHF MLLT3 TCF7L2 CMSS1 ADAMTSL3	3.62e-03	329	222	8	EFO_0007843
Disease	retinal nerve fibre layer thickness measurement	PTPRD ALDH6A1 GRB10	4.15e-03	43	222	3	EFO_0600004
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	RARA IGF2R	4.16e-03	13	222	2	DOID:332 (biomarker_via_orthology)
Disease	X-24588 measurement	DNMBP HEATR4	4.16e-03	13	222	2	EFO_0800898
Disease	peak insulin response measurement	CDKAL1 TCF7L2	4.16e-03	13	222	2	EFO_0008000
Disease	GDH/6PGL endoplasmic bifunctional protein measurement	H6PD OVCH1	4.83e-03	14	222	2	EFO_0801619
Disease	5-methyluridine (ribothymidine) measurement	PTPRS PCLO	4.83e-03	14	222	2	EFO_0020013
Disease	Disorder of eye	TSPAN12 BBS4 USH2A FOXE3 ABHD12 TCTN2	5.52e-03	212	222	6	C0015397
Disease	amino acid measurement	WWOX OR2F1 ALG1 IPO5 OR2F2 CARMIL1 SMURF1 GRB10 DNAH12 TNKS2 HBE1 MUC2	5.53e-03	678	222	12	EFO_0005134
Disease	granulysin measurement	ERAP2 SLFN12L	5.55e-03	15	222	2	EFO_0008144
Disease	X-17654 measurement	HEATR4 FUT2	5.55e-03	15	222	2	EFO_0800784
Disease	Squamous cell carcinoma of esophagus	WWOX NFE2L2 SLC39A6 KDM6A	5.82e-03	95	222	4	C0279626
Disease	5-oxoproline measurement	RMI1 DNAH8	6.31e-03	16	222	2	EFO_0010988
Disease	sickle cell anemia (is_implicated_in)	APOB HBE1	6.31e-03	16	222	2	DOID:10923 (is_implicated_in)
Disease	Pontoneocerebellar hypoplasia	PCLO TBC1D23	6.31e-03	16	222	2	cv:C1261175
Disease	Cardiomyopathy, Familial Idiopathic	UCP1 PNPLA2 TCF7L2	6.35e-03	50	222	3	C1449563
Disease	Crohn Disease	ERAP2 FUT2 MUC2	6.35e-03	50	222	3	C0010346
Disease	serum alanine aminotransferase measurement	RAD18 PDE4C MAP3K20 ETV5 DNMBP TRIM46 DIP2B ANPEP SH2B3 PCLO APOB XPO1 LTN1 FUT2	6.38e-03	869	222	14	EFO_0004735
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	FCGRT APOB PPP2R3A IGF2R FUT2 TNKS2	6.59e-03	220	222	6	EFO_0004529, EFO_0008317
Disease	obsolete_red blood cell distribution width	PLCL2 GMPR RMND1 ZC3H7B ALDH6A1 DIP2B OGT L3MBTL2 CHAF1A CARMIL1 ARPC1A MKRN2OS APOB SLFN12L WDCP ASB3 LRRC14 SLC12A7 HBE1	6.62e-03	1347	222	19	EFO_0005192
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	NRBP1 TCF7L2 APOB	6.71e-03	51	222	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	sitting height ratio	PRKD2 TCF7L2 ADAMTSL3	6.71e-03	51	222	3	EFO_0007118
Disease	attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder	PTPRF TCF7L2 PCLO	6.71e-03	51	222	3	EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090
Disease	Vitiligo	NFE2L2 SH2B3	7.11e-03	17	222	2	C0042900
Disease	extrahepatic cholestasis (biomarker_via_orthology)	NFE2L2 LGALS1	7.11e-03	17	222	2	DOID:13619 (biomarker_via_orthology)
Disease	neurotic disorder	PLCL2 ZC3H7B PCLO ASXL3	7.21e-03	101	222	4	EFO_0004257
Disease	total blood protein measurement	RMI1 FCGRT TCF7L2 SH2B3 ARHGEF12 DGKE XPO1 SLC7A1 MACF1	7.24e-03	449	222	9	EFO_0004536

Protein segments in the cluster

Peptide	Gene	Start	Entry
IQNAPEQACHLAKTA	YWHAG	186	P61981
VNHCRFSPDDKLLAS	APAF1	746	O14727
LFHKLEGCVNFPSSQ	ERICH6	606	Q7L0X2
FNCQSLHKLSLPDND	ERBIN	66	Q96RT1
DNIEGPIALKFSHLC	EPGN	46	Q6UW88
YAEAVHLDKCNPLVN	BBS4	361	Q96RK4
HLDKCNPLVNLNYAV	BBS4	366	Q96RK4
LGFCNSKPHDELLQN	ALG1	66	Q9BT22
DVSLHALGKNCPFLQ	AMN1	156	Q8IY45
AKTDCALHRIQNLAP	APBB2	241	Q92870
PDHSQLLQALCAAVA	ARAP3	611	Q8WWN8
TPDSKQCNNFLLHNL	CACNA2D2	716	Q9NY47
FHSLALVQCLPSQDL	ALS2	211	Q96Q42
DGKVIQLHDQLFSCP	ACTRT3	241	Q9BYD9
HLRCEKLTFNNPTED	MLLT3	116	P42568
HPNNVLLAAGSCDFK	ARPC1B	151	O15143
HVISQDFDSPCLKNK	APTX	276	Q7Z2E3
NKECAHLLLAHNAPV	ANKRD13C	156	Q8N6S4
GQPSACLHFKQLATL	CACHD1	636	Q5VU97
NLPDSCFLKANDLTH	CMSS1	116	Q9BQ75
LCSFRKLLNPHQVFD	DGKQ	606	P52824
KSLGLCPQHDILFDN	ABCA3	606	Q99758
QLAKCVSSPHFQVAE	PPP2R5D	406	Q14738
CDFVHQALEQLKPLL	DNMBP	1191	Q6XZF7
IINDAFNLASAHKVP	ANPEP	661	P15144
VLCSFKAHLNPQDRS	ANKRD24	166	Q8TF21
AFHPDLCSQLDQLLQ	CHAF1A	486	Q13111
FCLTLKALPHLIQDA	DNAJC1	231	Q96KC8
ELLLDHQAVFSQCPA	DISP2	1216	A7MBM2
PTNCDVALFELALHL	CFAP44	1541	Q96MT7
IFASDACKNVTLHVP	DSC2	26	Q02487
LPSCSFQQNLFHVDK	ASXL3	1901	Q9C0F0
KFLSTAQAICLADQP	ADAMTS16	481	Q8TE57
NDVLHCVAFAVPKSS	A2M	81	P01023
KHAAATFCSNQPFAL	ARHGEF12	881	Q9NZN5
HPNNVLLAAGSCDFK	ARPC1A	151	Q92747
VRKAHQETFPALCQL	RARA	191	P10276
NAQCDALHPKSAAEI	RAD18	286	Q9NS91
LCAILQHFNLKPLVD	CYP2E1	451	P05181
DLAFAHLNSPQLACL	EDC4	181	Q6P2E9
HKLDKQLAEPQCSFE	GOLGA6A	436	Q9NYA3
FSHAKQLFAACLELV	INTS8	586	Q75QN2
AEILHFCTNDQLLPK	PIK3C2G	316	O75747
FCTNDQLLPKDHILS	PIK3C2G	321	O75747
FQLCAQSKEKTHLPD	LTN1	851	O94822
KFANDENVKHISCPL	ABHD12	311	Q8N2K0
INCKVNGHPLKAFVD	DDI1	246	Q8WTU0
PFLNVNCEHIKSFDK	MCM4	206	P33991
NFICDHPDIKAISFV	ALDH6A1	246	Q02252
ASCLREHAPFLVANA	PNPLA2	26	Q96AD5
ANTIPHVFCDLAALL	OR1J2	171	Q8NGS2
LRHNLSFNDCFIKIP	FOXB2	61	Q5VYV0
SLNAKPHDSLDLNCD	KCND1	576	Q9NSA2
QPLAVLAFHSAAVQC	GNB1L	286	Q9BYB4
GKDSNNLCLHFNPRF	LGALS1	36	P09382
HLPNCASALDFIKLD	NLRC4	601	Q9NPP4
NLKPAFAKLSELHCD	HBE1	81	P02100
SHAIFPATFCQKNDI	L3MBTL2	481	Q969R5
SFVNASCAHPQLLKG	LRIG3	466	Q6UXM1
ALFNLSCSHLNLAEK	FRMD7	26	Q6ZUT3
APLLFTCSNLDLNNH	GPR137C	406	Q8N3F9
VDFCNKPILLHQVEA	GMPPB	26	Q9Y5P6
SLKHFQLALVDCNPC	KDM6A	186	O15550
LVNGLFHDLCQPTRK	DDX60	1456	Q8IY21
AHATEILARFPCKEN	CALHM2	151	Q9HA72
EIASFQVAAHLKCPI	FBXW12	331	Q6X9E4
ANKELTFLLFSCPHR	FCGRT	171	P55899
ELLLHVPEKANFNTC	PCLO	596	Q9Y6V0
LFPKFLHQNLAESAA	PCNX2	1066	A6NKB5
CANFLVPSQNLHLTL	LENG9	351	Q96B70
PLCQLIKDSLFAQCH	MUC2	4691	Q02817
HLAVGFKLLQAENCD	PDE4C	461	Q08493
ELCTLKHPFEGNNLQ	NEK5	196	Q6P3R8
QLVLKICQAHFAPIS	NEK5	211	Q6P3R8
DLSLCKAFNQNHPES	NFE2L2	321	Q16236
FCPHHLVNSESKANI	DCAF8	376	Q5TAQ9
APSCKLLFEVHNIEN	DNAH8	2236	Q96JB1
QSSNFLFPKACHQRA	IL16	121	Q14005
QTKQLFLEGSLHPCN	DIP2B	916	Q9P265
ACNVHNLQPVKFFLE	DNAH12	1501	Q6ZR08
DPKFLVNLDPSHCSN	MED15	686	Q96RN5
LQEALLHCGKFQDAL	MACF1	1466	O94854
LHCGKFQDALEPLLS	MACF1	1471	O94854
PAASELAHVKQLACS	PRKD2	61	Q9BZL6
ACEQIGLKEAQLFHP	LMO7	131	Q8WWI1
KACRLNPALADELHS	LRP2BP	326	Q9P2M1
PLQFTLHCALLANKT	LRPPRC	406	P42704
RKCSAEQFDLPQDHL	METTL18	46	O95568
KQFCLQNAQHDPLLT	GNG5	36	P63218
DNQRPFLKAESECHL	ETV5	461	P41161
KNISPADAHRNLCLA	NLRP2	736	Q9NX02
LAEHKAIPFQSCAAQ	OR2F1	86	Q13607
LAEHKAIPFQSCAAQ	OR2F2	86	O95006
HAAAALINFTEDCPK	IPO5	461	O00410
HKLDKQLAEPQCSFE	GOLGA6B	436	A6NDN3
ILLGPDRFKHINNCA	IMPACT	271	Q9P2X3
VCADLLHIPVSQFKD	PPP2R3A	51	Q06190
HKERCIAASLELNNP	GTSE1	41	Q9NYZ3
LRNSKNCTEPALHEF	SLC24A3	81	Q9HC58
LTCQEKLHPALDSFD	PNOC	26	Q13519
LRHNLSFNDCFIKIP	FOXB1	61	Q99853
CLRNSLPKVLNFHNF	IFNAR2	271	P48551
ALFEVPSLKLLAAHC	NRBP1	326	Q9UHY1
SNKINHFFCDGLPIL	OR5AK3P	171	Q8NH89
KAHTSRFISANLPCN	PTPRS	1691	Q13332
LQHLCVAHNKLSVAP	PODNL1	126	Q6PEZ8
NALKLFPVQPCSAVH	FAM189A2	66	Q15884
CLHPLANETFVAKDN	FHL1	71	Q13642
VAEAICKEQHLFLPF	APOB	256	P04114
NCQALDKATPLFIAA	ASB3	206	Q9Y575
CAALLKHINDSAPEV	CKAP5	441	Q14008
QAVQPHLRKCFDSIS	DNAH6	1211	Q9C0G6
PDSTIALNLKACNHF	TTC26	216	A0AVF1
QKDFPAHRIVLAACS	KLHL12	41	Q53G59
LIICNTKFDHLPARN	CASP5	196	P51878
ATLPITFKCLLENNH	SLC1A7	346	O00341
LNSCTVKNPAEDHFR	CDKAL1	106	Q5VV42
PAKDFALLTQCNHTI	FUT2	271	Q10981
HLLDTNQLDANCIPF	EHF	61	Q9NZC4
PHSVAKSQCLENSLF	GUSB	636	P08236
LFLSPNLDSHGLKCA	C3orf38	211	Q5JPI3
LLNPAVHFAQVVKEC	DDX11L8	601	A8MPP1
QAPHKLDDCTLQLSH	FHOD3	51	Q2V2M9
LPALEAALCDKNAHV	HEATR4	531	Q86WZ0
CHIAQFKSLSPQELQ	IFNL2	41	Q8IZJ0
GCHIAQFKSLSPQEL	IFNL3	36	Q8IZI9
HKLDKQLAEPQCSFE	GOLGA6C	436	A6NDK9
DTSLPDKCNSFLHNK	MAP3K20	266	Q9NYL2
LCNEKLHNAAPTRTA	LY6D	91	Q14210
LNHAPCIQKAAELFS	ERAP2	761	Q6P179
HKLDKQLAEPQCSFE	GOLGA6D	436	P0CG33
LNLTCHADNAKPAAS	KIRREL3	166	Q8IZU9
DSQSNPKAFVLTLCH	GRB10	521	Q13322
LNHDLKVPCNFSVTA	DBR1	331	Q9UK59
DFAQKLASALAHNPN	CARMIL1	261	Q5VZK9
AEKPLCLSNENASHV	ITGA7	776	Q13683
HPFKDLLLTCAQDRQ	EML4	601	Q9HC35
DILCLTVNQHPKFIN	EML5	1416	Q05BV3
PDLHLFQCDEVKANL	EPS8	161	Q12929
GHSVLKENAFCNLAA	CCDC168	2616	Q8NDH2
FHCAQIQVKLANPFR	DGKE	486	P52429
HKIVNSFLCLVPDDA	FHIP2A	566	Q5W0V3
KLFATNHPECLQNVA	GMPR	86	P36959
KLSLNFHSLCEQQPI	GRK7	51	Q8WTQ7
APSHCAEHKDQFLQL	H6PD	91	O95479
PSLKNEFNLVCDRKH	SLC22A13	121	Q9Y226
AHQALLVAKNVDSFP	SLC12A7	821	Q9Y666
HSDLKSCVPLNTNEL	CAMSAP2	506	Q08AD1
HNLSLNDCFVKIPRE	FOXD3	191	Q9UJU5
AAAQAAQQKFHLVPS	FOSL1	26	P15407
AHTSRFISANLPCNK	PTPRF	1651	P10586
HFIDLSQIPCNGKAA	OGT	611	O15294
INHFFCEIPAVLKLA	OR2T11	171	Q8NH01
LDFVCSFLQKNRKHP	NUMA1	61	Q14980
FLDNACHQLSLSLVP	PKN3	391	Q6P5Z2
AHTSRFISANLPCNK	PTPRD	1656	P23468
NLPSQLAHRLAEKSC	RFC3	206	P40938
IFTELHVQVCNKAPA	MROH2A	346	A6NES4
AHDRLACDPNTKFAA	RNF150	96	Q9ULK6
LPTCDLADQHNIKFH	MAP3K15	311	Q6ZN16
EHYLINVCKSLAPQA	IGF2R	1401	P11717
PHALEFLRKDCANVN	RIOK1	351	Q9BRS2
QDPATFHLLAQNLIC	RTL4	161	Q6ZR62
LLIFHNVCFSPANKP	RTTN	2121	Q86VV8
HLDVNNLLGCSKTPF	USH2A	1041	O75445
DVPALQLQYDHCKAL	UTRN	2591	P46939
PCFVQAAKQLHNRIA	TRIM46	376	Q7Z4K8
FIDICKNLPHTNIAS	SLC26A9	241	Q7LBE3
NLCFEGNLTPKLLHS	LIAT1	431	Q6ZQX7
QPAHFSQCSNLKELQ	LRRC15	141	Q8TF66
AKDIFIEAHLCLNNS	MRPL45	141	Q9BRJ2
CNVPLAHDFTNKEKN	RMI1	406	Q9H9A7
FQNLHRKLSECVPSL	SNX25	556	Q9H3E2
LTAAHCVQLKNNPLS	OVCH1	611	Q7RTY7
SLNECHPVNFLAKIF	FASTKD3	456	Q14CZ7
CLAPLAKVIHDNFGI	GAPDH	156	P04406
QKTNLPALNRFCHAA	GPER1	341	Q99527
PALNRFCHAALKAVI	GPER1	346	Q99527
KQIHFAAVSCGLNKP	PLCL2	1086	Q9UPR0
HNLTLNDCFVKVPRE	FOXE3	121	Q13461
NLFQLGHKCAAVLDL	SHLD2	166	Q86V20
PKLNDNVSAYCLHIA	MAPKAP1	221	Q9BPZ7
SPLNAARCQDEKAHL	RMND1	81	Q9NWS8
NFPQEVKDLLSCNHT	SDAD1	76	Q9NVU7
ISSHCRLDKSNFQQP	IL22	36	Q9GZX6
EHINAKCPNLEFVGL	PLPBP	166	O94903
AVCLAPSLFHLNTLK	DLC1	1226	Q96QB1
CHSALLDLEKLPEFN	EARS2	341	Q5JPH6
LIDANTDNLPKAHTC	SMURF1	711	Q9HCE7
TDNLPKAHTCFNRID	SMURF1	716	Q9HCE7
LINSTFLHNKEGCPL	SV2A	571	Q7L0J3
PQECFNASKLLTSHG	SLC39A6	261	Q13433
CPRFVAHSVLENAKN	TRAF5	521	O00463
DLHQTKCLRFNPDAT	SHANK1	81	Q9Y566
SDFNNKHLLEPLCSD	TASOR	1126	Q9UK61
KKVNEFCNRSSHLDP	RNF17	446	Q9BXT8
FRNHKFADLPCELQD	TJAP1	186	Q5JTD0
AFVKNNILADDVPCH	UCP1	201	P25874
FRSALSVCPLNAKVH	TMTC4	471	Q5T4D3
FNHKALQLLHCFPLD	UBA6	711	A0AVT1
LLQAVNSHCFPAFLA	XPO1	851	O14980
AHPGCEKAFTQLSNL	ZNF384	376	Q8TF68
AFAQCPKAVHNSVAA	ZCCHC3	381	Q9NUD5
KEFVPKHARQCNTLA	MIOS	106	Q9NXC5
TLANKHANQVLSLPC	MITF	146	O75030
PFTNGHQEKCSFLLR	MKRN2OS	51	H3BPM6
DVLSAAPQHAKSRCQ	RNF112	391	Q9ULX5
HLLKSNCIPQATALS	RLF	221	Q13129
PKTFCRNLFSQHEGL	SLFN12L	411	Q6IEE8
NESKFPLDNCHASKA	SSH2	561	Q76I76
CLDNNSPLPDAFKHV	SLC7A1	316	P30825
RCHDKDINSVAIAPN	TBL3	476	Q12788
LPEQNTIHKDCLQFI	TBC1D23	76	Q9NUY8
LLAEATHKASALCPN	TCF7L2	556	Q9NQB0
NCNESFKLPFQLAQH	ZNF654	821	Q8IZM8
AFKAKNVPLHVLVCN	WWOX	196	Q9NZC7
NVPLHVLVCNAATFA	WWOX	201	Q9NZC7
PIRKFICASNQNHVL	THNSL1	526	Q8IYQ7
GLLDPACQKTDHFLS	SH2B3	346	Q9UQQ2
SKLCPAANTLNEIFL	REP15	46	Q6BDI9
QLCALSKHPTVAFED	SEMA5B	96	Q9P283
PTTALKHAECLLDLN	UNQ9370/PRO34162	101	Q6UXP9
DNSQHLSCPSVELLK	TSPAN12	266	O95859
SFLQPELVKLQHCGD	PSME4	786	Q14997
ADPTLLNCHNKSAID	TNKS2	301	Q9H2K2
NALAQHCRFPLLSKL	ZNF862	1011	O60290
CPKAFAQSSSLIEHQ	ZSCAN22	441	P10073
DALHCFFQPRELSSK	USP41	211	Q3LFD5
QHCNHLFATKPELLF	ZMYM6	431	O95789
HCAALKVFTAIANQP	PSMD5	411	Q16401
DALHCFFQPRELSSK	USP18	211	Q9UMW8
TNCDKHFNEKPNLAL	ZNF597	271	Q96LX8
RKHFCQEILDFASQP	TRAPPC10	556	P48553
KKLIESLSPDFCHQN	WDCP	461	Q9H6R7
SLSPDFCHQNKGLLL	WDCP	466	Q9H6R7
QGHFCKLFASLVPND	UBR2	1386	Q8IWV8
AFDHLCNKIIATRNP	TENT5A	271	Q96IP4
SVPACHELKAFANQG	ZNF71	71	Q9NQZ8
HELKAFANQGCVLVP	ZNF71	76	Q9NQZ8
SSKDHSCPQNLDLFV	ZNF317	26	Q96PQ6
QNAPVAFLHNFDVKC	TCTN2	306	Q96GX1
PLNHKRFVCDLTQAD	SNRNP48	146	Q6IEG0
KVPNACLFTINKEDH	POLR2J	26	P52435
IKNPLAATHEFKQAC	ZC3H7B	411	Q9UGR2
ALPALTLCEKNHSAF	ZSWIM4	771	Q9H7M6
SEALCDHLQKPLAGF	ADAMTSL3	1461	P82987
VVLNCDALSHFPALL	KPNA4	321	O00629
FPLLSFQQLLQECAH	LRRC14	56	Q15048
QLRKNETLFHSCSAP	NLRP13	411	Q86W25
APACKHLSDALLQNR	NLRP13	881	Q86W25